Connor, Clark & Lunn Investment Management (CC&L)’s Assembly Biosciences ASMB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$604K	Buy	21,761 +959	+5%	+$27.4K	﹤0.01%	1274
2025 Q4	$707K	Buy	20,802 +9,646	+86%	+$311K	﹤0.01%	1229
2025 Q3	$286K	Buy	+11,156	New	+$245K	﹤0.01%	1370
2025 Q2	–	Sell	-10,182	Closed	-$97.3K	–	1501
2025 Q1	$97.3K	Sell	10,182 -631	-6%	-$8.25K	﹤0.01%	1352
2024 Q4	$171K	Buy	+10,813	New	+$174K	﹤0.01%	1340
2023 Q1	–	Sell	-5,449	Closed	-$85K	–	1236
2022 Q4	$85K	Sell	5,449 -5,364	-50%	-$91.7K	﹤0.01%	1121
2022 Q3	$213K	Sell	10,813 -1,097	-9%	-$26.5K	﹤0.01%	986
2022 Q2	$300K	Sell	11,910 -1,836	-13%	-$42.3K	﹤0.01%	864
2022 Q1	$340K	Sell	13,746 -439	-3%	-$9.43K	﹤0.01%	848
2021 Q4	$397K	Buy	14,185 +1,150	+9%	+$37.7K	﹤0.01%	842
2021 Q3	$544K	Buy	13,035 +395	+3%	+$16.6K	﹤0.01%	756
2021 Q2	$589K	Buy	12,640 +1,078	+9%	+$53.4K	﹤0.01%	760
2021 Q1	$638K	Buy	+11,562	New	+$766K	﹤0.01%	761
2020 Q2	–	Sell	-1,333	Closed	-$237K	–	1007
2020 Q1	$237K	Buy	+1,333	New	+$286K	﹤0.01%	840